Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses, Immunity, vol.27, pp.111-122, 2007. ,
Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family, Immunol Rev, vol.241, pp.180-205, 2011. ,
Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections, Immunol Rev, vol.229, pp.67-87, 2009. ,
CD28-specific immunomodulating antibodies: what can be learned from experimental models?, Am J Transplant, vol.12, pp.1682-1690, 2012. ,
What's the difference between CD80 and CD86?, Trends Immunol, vol.24, pp.314-319, 2003. ,
Up-regulation of cFLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells, Eur J Immunol, vol.30, pp.2765-2774, 2000. ,
CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes, Eur J Immunol, vol.29, pp.789-798, 1999. ,
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4, Science, vol.270, pp.985-988, 1995. ,
CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction, J Immunol, vol.160, pp.12-15, 1998. ,
CTLA-4 can function as a negative regulator of T cell activation, Immunity, vol.1, pp.405-413, 1994. ,
Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking, Proc Natl Acad Sci, vol.95, pp.10083-10088, 1998. ,
Reversal of the TCR stop signal by CTLA-4, Science, vol.313, pp.1972-1975, 2006. ,
CTL-associated antigen-4 ligation induces rapid T cell polarization that depends on phosphatidylinositol 3-kinase, Vav-1, Cdc42, and myosin light chain kinase, J Immunol, vol.179, pp.400-408, 2007. ,
Interaction of human PD-L1 and B7-1, Mol Immunol, vol.45, pp.3567-3572, 2008. ,
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal, Nat Immunol, vol.10, pp.1185-1192, 2009. ,
B7/ CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes, Immunity, vol.12, pp.431-440, 2000. ,
CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells, J Immunol, vol.172, pp.2778-2784, 2004. ,
The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology, Immunol Rev, vol.212, pp.131-148, 2006. ,
Foxo transcription factors control regulatory T cell development and function, Immunity, vol.33, pp.890-904, 2010. ,
Foxo1 and Foxo3 help Foxp3, Immunity, vol.33, pp.835-837, 2010. ,
CTLA-4 control over Foxp3+ regulatory T cell function, Science, vol.322, pp.271-275, 2008. ,
CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria, Mucosal Immunol, 2012. ,
IDO expression by dendritic cells: tolerance and tryptophan catabolism, Nat Rev Immunol, vol.4, pp.762-774, 2004. ,
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4, Science, vol.332, pp.600-603, 2011. ,
Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation, Proc Natl Acad Sci U S A, vol.105, pp.10113-10118, 2008. ,
Biologics in organ transplantation, Transpl Int, vol.25, pp.707-719, 2012. ,
Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab' Antibody, Am J Transplant, 2012. ,
B7-h2 is a costimulatory ligand for CD28 in human, Immunity, vol.34, pp.729-740, 2011. ,
Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab' antibody, Am J Transplant, vol.12, pp.2630-2640, 2012. ,
The T cell repertoire selected in vitro against EBV: diversity, specificity, and improved purification through early IL-2 receptor alpha-chain (CD25)-positive selection, J Immunol, vol.164, pp.4924-4932, 2000. ,
Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media, Clin Exp Immunol, vol.144, pp.158-168, 2006. ,
URL : https://hal.archives-ouvertes.fr/inserm-00473461
Regulatory T cells: recommendations to simplify the nomenclature, Nat Immunol, vol.14, pp.307-308, 2013. ,
Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression, Blood, vol.106, pp.1694-1702, 2005. ,
Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation, Sci Transl Med, vol.2, pp.17-27, 2010. ,
Antagonist properties of monoclonal antibodies targeting human CD28: Role of valency and the heavy-chain constant domain, MAbs, vol.5, 2012. ,
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4, J Exp Med, vol.192, pp.303-310, 2000. ,
Protein kinase C-theta mediates negative feedback on regulatory T cell function, Science, vol.328, pp.372-376, 2010. ,
LFA-1-mediated T cell costimulation through increased localization of TCR/class II complexes to the central supramolecular activation cluster and exclusion of CD45 from the immunological synapse, J Immunol, vol.179, pp.1616-1624, 2007. ,
A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in Tcell contacts, Cell, vol.94, pp.667-677, 1998. ,
Threedimensional segregation of supramolecular activation clusters in T cells, Nature, vol.395, pp.82-86, 1998. ,
FR255734, a humanized, Fc-Silent, Anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model, J Invest Dermatol, vol.128, pp.1969-1976, 2008. ,
Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis, J Immunol, vol.163, pp.1704-1710, 1999. ,
Blockade of costimulation through B7/CD28 inhibits experimental autoimmune uveoretinitis, but does not induce long-term tolerance, J Immunol, vol.165, pp.5041-5047, 2000. ,
Anti-CD28 Antibody-Induced Kidney Allograft Tolerance Related to Tryptophan Degradation and TCR Class II B7 Regulatory Cells, Am J Transplant, vol.5, pp.2339-2348, 2005. ,
Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner, Am J Transplant, vol.11, pp.1599-1609, 2011. ,
Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men, Hum Immunol, vol.65, pp.282-290, 2004. ,
Alternatives to calcineurin inhibition in renal transplantation: belatacept, the first co-stimulation blocker, Immunotherapy, vol.2, pp.625-636, 2010. ,
Antigenspecific suppression and immunological synapse formation by regulatory T cells require the mst1 kinase, PLoS One, vol.8, p.73874, 2013. ,
Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal, Blood, vol.120, pp.4560-4570, 2012. ,
CTLA-4 upregulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function, Proc Natl Acad Sci U S A, vol.102, pp.12861-12866, 2005. ,
Regulation of the small GTPase Rap1 and extracellular signal-regulated kinases by the costimulatory molecule CTLA-4, Mol Cell Biol, vol.25, pp.4117-4128, 2005. ,
Small GTPases and LFA-1 reciprocally modulate adhesion and signaling, Immunol Rev, vol.218, pp.114-125, 2007. ,
Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression, J Immunol, vol.188, pp.1698-1707, 2012. ,
Cell-intrinsic and -extrinsic control of Treg-cell homeostasis and function revealed by induced CD28 deletion, Eur J Immunol, vol.43, pp.188-193, 2013. ,
Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells, J Immunol, vol.171, pp.3348-3352, 2003. ,
Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade, Transpl Immunol, vol.17, pp.243-248, 2007. ,
CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis, J Clin Immunol, vol.31, pp.588-595, 2011. ,
Decreased frequency of peripheral CD4(+) CD161(+) Th(17) -precursor cells in kidney transplant recipients on long-term therapy with Belatacept, Transpl Int, vol.25, pp.455-463, 2012. ,